Anti-EIF5 抗体
Anti-EIF5 antibody
- JP Deleterious:医薬用外劇物
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Polyclonal EIF5 antibody. Suitable for WB, IHC-P and reacts with Mouse, Rat, Human samples. Cited in 4 publications. Immunogen corresponding to Recombinant Fragment Protein within Human Eukaryotic translation initiation factor 5.
別名を表示する
Eukaryotic translation initiation factor 5, eIF-5, EIF5
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-EIF5 antibody (AB228874)
Paraffin-embedded human colon carcinoma tissue stained for EIF5 with ab228874 at 1/500 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-EIF5 antibody (AB228874)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-EIF5 antibody (ab228874) at 1/1000 dilution
All lanes:
U-87 MG (human glioblastoma-astrocytoma epithelial cell line) whole cell lysate at 30 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG
Predicted band size: 49 kDa
false
- WB
Supplier Data
Western blot - Anti-EIF5 antibody (AB228874)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-EIF5 antibody (ab228874) at 1/1000 dilution
All lanes:
Rat brain lysate at 50 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG
Predicted band size: 49 kDa
false
- WB
Unknown
Western blot - Anti-EIF5 antibody (AB228874)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-EIF5 antibody (ab228874) at 1/1000 dilution
All lanes:
Mouse brain lysate at 50 µg
Secondary
All lanes:
HRP-conjugated anti-rabbit IgG
Predicted band size: 49 kDa
false
- WB
CiteAb
Western blot - Anti-EIF5 antibody (AB228874)
EIF5 western blot using anti-EIF5 antibody ab228874. Publication image and figure legend from Godel, M., Morena, D., et al., 2020, Int J Mol Sci, PubMed 32599901.
ab228874 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab228874 please see the product overview.
SNORD3A, SNORA13 and SNORA28 up-regulation in doxorubicin-resistant osteosarcoma cells. (A) mRNA levels of SNORD3A, SNORA13 and SNORA28 and their host genes (OSCP1, EPB41L4A and EIF5) were evaluated by RT-PCR, in triplicates. Data are means ± SD (n = 3). * p < 0.05, *** p < 0.001 : DX-variants vs. U-2OS cells. (B) Linear correlation between the relative expression of snoRNAs and the relative expression of the host genes, according to the RT-PCR results of Figure 2A. (C) Immunoblot of the indicated proteins. The figure is representative of one out of three experiments. Tubulin was used as control of equal protein loading.
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EIF5 facilitates the translation initiation process which is critical for protein synthesis. It is an integral component of the multifactor eIF2 complex that ensures the accuracy of start codon recognition in mRNA. This complex assembly involves the association with other initiation factors like eIF1 and eIF3 orchestrating mRNA scanning and the selection of the start site for protein synthesis. EIF5's role in regulating protein biosynthesis links it to the maintenance of cellular homeostasis.
Pathways
EIF5 serves a critical part in the translation initiation pathway. This pathway is essential for general protein biosynthesis directly impacting cellular growth and proliferation. It closely collaborates with related factors like eIF2 and eIF2B within this pathway to modulate translation in response to cellular stress and nutrient availability. Additionally EIF5 intersects the mTOR signaling pathway where it interacts with proteins that coordinate cell growth and metabolism under various physiological conditions.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (4)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:1362 PubMed38355937
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 9:1062695 PubMed36568562
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32599901
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 12:3611-3621 PubMed32547198
2020
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com